|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2010-11-5
|
|
pubmed:abstractText |
Median survival in stage II adrenocortical carcinoma (ACC) differs widely in published series ranging between 23 and more than 60 months. We hypothesized that these results may have been affected by a referral bias because many patients may contact specialized centers only after recurrence.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1945-7197
|
|
pubmed:author |
pubmed-author:AghaAymanA,
pubmed-author:AllolioBrunoB,
pubmed-author:BeuschleinFelixF,
pubmed-author:FührerDagmarD,
pubmed-author:FassnachtMartinM,
pubmed-author:FenskeWiebkeW,
pubmed-author:German ACC Registry Group,
pubmed-author:HahnerStefanieS,
pubmed-author:JohanssenSarahS,
pubmed-author:JurowichChristianC,
pubmed-author:PetersennStephanS,
pubmed-author:QuinklerMarcusM,
pubmed-author:SpahnMartinM,
pubmed-author:WeismannDirkD
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
95
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4925-32
|
|
pubmed:meshHeading |
pubmed-meshheading:20668036-Adolescent,
pubmed-meshheading:20668036-Adrenal Cortex Neoplasms,
pubmed-meshheading:20668036-Adrenocortical Carcinoma,
pubmed-meshheading:20668036-Adult,
pubmed-meshheading:20668036-Aged,
pubmed-meshheading:20668036-Aged, 80 and over,
pubmed-meshheading:20668036-Antineoplastic Agents, Hormonal,
pubmed-meshheading:20668036-Chemotherapy, Adjuvant,
pubmed-meshheading:20668036-Chi-Square Distribution,
pubmed-meshheading:20668036-Female,
pubmed-meshheading:20668036-Follow-Up Studies,
pubmed-meshheading:20668036-Humans,
pubmed-meshheading:20668036-Kaplan-Meier Estimate,
pubmed-meshheading:20668036-Male,
pubmed-meshheading:20668036-Middle Aged,
pubmed-meshheading:20668036-Mitotane,
pubmed-meshheading:20668036-Neoplasm Recurrence, Local,
pubmed-meshheading:20668036-Neoplasm Staging,
pubmed-meshheading:20668036-Prognosis,
pubmed-meshheading:20668036-Referral and Consultation,
pubmed-meshheading:20668036-Registries,
pubmed-meshheading:20668036-Statistics, Nonparametric,
pubmed-meshheading:20668036-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers.
|
|
pubmed:affiliation |
Department of Internal Medicine I, University Hospital, University of Würzburg, Würzburg, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
